GLP-1 Market
LLY $1149.85 ▼ -0.6% NVO $37.40 ▼ -1.3% PFE $28.12 ▼ -1.4% VKTX $30.51 ▼ -6.4% KLRA $11.03 ▼ -3.4% GPCR $28.98 ▼ -7.3% RHHBY $52.35 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Dextrose 20%

Company
David D'Alessio, M.D.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 2, 2026

Find a Clinical Trial Near Me

See recruiting studies for Dextrose 20% and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04832009

    Reversing Glucose and Lipid-mediated Vascular Dysfunction

    Not yet reported University of Kansas Medical Center 46 participants Est. completion 2027-08-01 1 site
    Other conditions: Blood Pressure, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06126419

    Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 70 participants Est. completion 2026-12 1 site
    Other conditions: Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration
    View official trial listing →
  • Recruiting NCT NCT06592261

    Graded Insulin Suppression Test P&F

    Not yet reported Columbia University 15 participants Est. completion 2026-09 1 site
    Other conditions: Insulin Resistance, Hyperinsulinemia, Obesity, Healthy
    View official trial listing →
  • Recruiting NCT NCT07224334

    Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

    Not yet reported David D'Alessio, M.D. 30 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Diabetes (DM)
    View official trial listing →
  • Recruiting NCT NCT07403604

    Effect of Insulin Lowering on Lipogenesis

    Not yet reported Columbia University 25 participants Est. completion 2029-09-30 1 site
    Other conditions: Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity
    View official trial listing →
  • Recruiting NCT NCT07778524

    Alpelisib Challenge Test (ACT)

    Not yet reported Columbia University 15 participants Est. completion 2028-08-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Resistance, Obesity & Overweight, Healthy Adult Participants
    View official trial listing →
  • Status unknown NCT NCT01001273

    Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 80 participants Est. completion 2012-06 1 site
    Other conditions: Postoperative Complications
    View official trial listing →
  • Completed NCT NCT01187329

    The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose

    Not yet reported The Cleveland Clinic 100 participants Est. completion 2013-12 1 site
    Other conditions: Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis, Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01528189

    Effect of High Dose Insulin on Infectious Complications Following Major Surgery

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 480 participants Est. completion 2025-09-01 3 sites
    Other conditions: Surgical Site Infection After Major Surgery
    View official trial listing →
  • Completed NCT NCT01706172

    Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection

    Not yet reported, Not yet reported Chisel Peak Medical Clinic 42 participants Est. completion 2016-06 1 site
    Other conditions: Temporomandibular Joint Disorders
    View official trial listing →
  • Completed NCT NCT01934868

    Prolotherapy Versus Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg

    Not yet reported Hadassah Medical Organization 110 participants Est. completion 2023-04-10 1 site
    Obstructive sleep apnea Other conditions: Sciatica, Spinal Stenosis of Lumbar Region
    View official trial listing →
  • Status unknown NCT NCT02032953

    Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 24 participants Est. completion 2024-04 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02053935

    Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

    Not yet reported Albert Einstein College of Medicine 15 participants Est. completion 2016-01 1 site
    Other conditions: Hyperglycemia, Sepsis
    View official trial listing →
  • Withdrawn NCT NCT02102243

    Neural Mechanism of Aldosterone-induced Insulin Resistance

    Not yet reported Wanpen Vongpatanasin Est. completion 2025-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02269735

    A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

    Not yet reported Merck Sharp & Dohme LLC 74 participants Est. completion 2016-07-29
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02549443

    The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 30 participants Est. completion 2015-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02746432

    Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial

    Not yet reported King Saud University 144 participants Est. completion 2021-03 1 site
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT03520569

    Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

    Not yet reported University of Virginia 15 participants Est. completion 2021-04-01 1 site
    Other conditions: Vascular Stiffness, Insulin Sensitivity
    View official trial listing →
  • Withdrawn NCT NCT04133922

    Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

    Not yet reported University of Virginia Est. completion 2024-10 1 site
    Other conditions: Type 1 Diabetes, Insulin Sensitivity/Resistance
    View official trial listing →
  • Suspended NCT NCT04207619

    Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

    Not yet reported Pennington Biomedical Research Center 10 participants Est. completion 2027-10 1 site
    Other conditions: Diabetes, Hypoglycemia
    View official trial listing →
  • Not yet recruiting NCT NCT06839430

    Therapeutic Effect of Using Injectable Hypertonic Saline 5% Versus Injectable Dextrose 20% on Pain in Painful Cases of Disc Displacement With Reduction

    Not yet reported Cairo University 20 participants Est. completion 2026-09-20
    Other conditions: TMJ Disc Displacement With Reduction
    View official trial listing →
  • Not yet recruiting NCT NCT07688096

    Regenerative Medicine for Joint Hypermobility and Instability

    Not yet reported, Not yet reported Manhattan Pain Medicine, PLLC 100 participants Est. completion 2028-12-31
    Other conditions: Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS), Joint Hypermobility, Joint Instability, Hypermobility Spectrum Disorder, Chronic Pain Syndrome, Musculoskeletal Pain, Sprain, Subluxation, Dislocation, Craniocervical Disfunction
    View official trial listing →
  • Active, not recruiting NCT NCT07798258

    Assessment of Injectable PRF Versus Dextrose Injection in Temporomandibular Joint in Anterior Disc Displacement With Reduction

    Not yet reported Cairo University 24 participants Est. completion 2027-02-10 1 site
    Other conditions: TMD
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Dextrose 20%, Dextrose 20% solution

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.